Comparative Efficacy and Safety of Vonoprazan-Amoxicillin Dual Therapy Versus Clarithromycin-Based Standard Triple Therapy for <i>Helicobacter pylori</i> Eradication: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

J Clin Med · 2026 · PMC13301928 · PMID 42355814

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In studies judged as high risk of bias, the effect did not reach statistical significance (RR 1.20; 95% CI [0.98; 1.46]; I 2 = 40%).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Comparative Efficacy and Safety of Vonoprazan-Amoxicillin Dual Therapy Versus Clarithromycin-Based Standard Triple Therapy for &lt;i&gt;Helicobacter pylori&lt;/i&gt; Eradication: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

The sentences

Comparative Efficacy and Safety of Vonoprazan-Amoxicillin Dual Therapy Versus Clarithromycin-Based Standard Triple Therapy for <i>Helicobacter pylori</i> Eradication: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.